![]() |
|
|
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Vol. 14, Issue 1, 274-287, January 2003

ois-Michel
Boisvert,*
and
*Terry Fox Molecular Oncology Group and the Bloomfield
Center for Research on Aging, Lady Davis Institute for Medical
Research, Sir Mortimer B. Davis Jewish General Hospital, and
Departments of Oncology, Medicine, Microbiology, and Immunology, McGill
University, Montréal, Québec, H3T 1E2 Canada; and
M.D. Anderson Cancer Center, Department of
Carcinogenesis, University of Texas, Smithville, Texas 78957
| |
ABSTRACT |
|---|
|
|
|---|
RNA binding proteins often contain multiple arginine glycine repeats, a sequence that is frequently methylated by protein arginine methyltransferases. The role of this posttranslational modification in the life cycle of RNA binding proteins is not well understood. Herein, we report that Sam68, a heteronuclear ribonucleoprotein K homology domain containing RNA binding protein, associates with and is methylated in vivo by the protein arginine N-methyltransferase 1 (PRMT1). Sam68 contains asymmetrical dimethylarginines near its proline motif P3 as assessed by using a novel asymmetrical dimethylarginine-specific antibody and mass spectrometry. Deletion of the methylation sites and the use of methylase inhibitors resulted in Sam68 accumulation in the cytoplasm. Sam68 was also detected in the cytoplasm of PRMT1-deficient embryonic stem cells. Although the cellular function of Sam68 is unknown, it has been shown to export unspliced human immunodeficiency virus RNAs. Cells treated with methylase inhibitors prevented the ability of Sam68 to export unspliced human immunodeficiency virus RNAs. Other K homology domain RNA binding proteins, including SLM-1, SLM-2, QKI-5, GRP33, and heteronuclear ribonucleoprotein K were also methylated in vivo. These findings demonstrate that RNA binding proteins are in vivo substrates for PRMT1, and their methylation is essential for their proper localization and function.
| |
INTRODUCTION |
|---|
|
|
|---|
Protein arginine methylation is a common posttranslational
modification in higher eukaryotes, but its precise role is not well
understood. Arginine methylation has been shown to affect several
cellular processes, including intracellular localization, protein-protein interactions as well as transcription (Gary and Clarke, 1998
; McBride and Silver, 2001
; Stallcup, 2001
). In yeast, Npl3p, Hrp1p, and Nab2p are shuttling proteins involved in the transport of mRNAs across the nuclear membrane (Anderson et
al., 1993
; Lee et al., 1996
). Arginine methylation of
these two heteronuclear ribonucleoproteins (hnRNPs) is required for
their nuclear export (Shen et al., 1998
; McBride et
al., 2000
; Green et al., 2002
). We have recently shown
that arginine methylation negatively affects the binding of
proline-rich ligands to Src homology 3 (SH3), but not WW, domain
protein modules (Bedford et al., 2000
). The methylation of
STAT1 is required for transcriptional activation by IFN
/
by
displacing PIAS1 (Mowen et al., 2001
). Arginine methylation can also have a positive effect on protein-protein interactions. The
spliceosomal snRNP proteins SmD1, D3 and B/B' contain symmetrically dimethylated arginines (sDMAs), and this modification is necessary for enhanced interaction with SMN (Brahms et al., 2000
,
2001
; Friesen et al., 2001a
,b
), the product of the spinal
muscular atrophy gene (Lefebvre et al., 1995
). Transcription
can also be regulated by arginine methylation through the modification
of histones and cofactors (Chen et al., 1999a
; Wang et
al., 2001
; Xu et al., 2001
).
The enzymes responsible for protein arginine methylation have been
classified in three groups (Gary and Clarke, 1998
). Type I enzymes
promote the formation of both
NG-monomethylated and asymmetric
-NG,NG-dimethylated
arginines (aDMAs). Type II enzymes catalyze the formation of
monomethylated and sDMAs. The type III enzyme found in yeast catalyzes
the monomethylation of the
-guanidino nitrogen atom of the arginine
residue. The known mammalian type I enzymes are protein arginine
N-methyltransferase (PRMT)1, PRMT3, coactivator-associated arginine methyltransferase 1 (CARM1), and PRMT6 (Lin et al.,
1996
; Tang et al., 1998
; Schurter et al., 2001
;
Frankel et al., 2002
). These PRMTs are ubiquitously
expressed and may serve multiple functions. PRMT1 is thought to be the
major PRMT accounting for >90% of the generation of aDMAs (Tang
et al., 2000
) and has been shown to be required for early
mouse postimplantation development (Pawlak et al., 2000
).
PRMT1 was first isolated through its interaction with BTG1 and TIS21,
two genes associated with cell quiescence (Lin et al.,
1996
). Most of the proteins identified as being targets of PRMT1 are
methylated within glycine-arginine rich (GAR) domains (Najbauer
et al., 1993
). Many proteins involved in RNA metabolism contain such regions with clustered arginine residues in an Arg-Gly-Gly motif (RGG box) or RG repeats (Burd and Dreyfuss, 1994
). Heteronuclear ribonucleoproteins (hnRNPs) represent a major protein family that contains methylated arginines (Liu and Dreyfuss, 1995
).
The K homology (KH) motif is a type of RNA binding domain found in a
large family of proteins associated with RNA metabolism (Gibson
et al., 1993
; Siomi et al., 1993
). A subfamily of
KH domain proteins contains an extended KH domain in a larger protein
module called the GRP33, Sam68, and
GLD-1 (GSD) domain (Jones and Schedl, 1995
). This family of
proteins includes the Src substrate associated in
mitosis of 68 kDa (Sam68; Wong et al.,
1992
; Fumagalli et al., 1994
; Taylor and Shalloway, 1994
),
Sam68 like mammalian protein 1 and 2 (SLM-1 and SLM-2; Di Fruscio et al., 1999
), Artemia
salina glycine rich protein (GRP33),
Caenorhabditis elegans germ-line defective 1 (GLD-1; Jones and Schedl, 1995
), and QUAKING
(QKI; Ebersole et al., 1996
). Although the cellular function
of Sam68 is unknown, it can functionally substitute for Rev in the
export of unspliced human immunodeficiency virus (HIV) RNAs (Reddy
et al., 1999
). The majority of KH domain RNA binding
proteins contain RGG boxes and RG-rich regions, making them potential
arginine methyltransferase targets.
Herein, we report that Sam68, SLM-1, SLM-2, GRP33, QKI-5, and hnRNP K
are methylated in vivo. Sam68 is asymmetrically methylated by PRMT1 in
vivo, as assessed by using a novel antiasymmetrically dimethylated
arginine antibody and ES cells harboring a prmt1 null
mutation. At steady state, Sam68 is predominantly nuclear, with no
cytoplasmic staining (Sam68/SLM nuclear bodies [SNBs]; Chen et
al., 1999b
). In PRMT1-deficient cells or cells treated with
methylase inhibitors a significant fraction of Sam68 resided in the
cytoplasm. The methylation of Sam68 is required to enhance the export
of unspliced HIV RNAs. Our findings demonstrate the necessity of
arginine methylation in the localization and function of KH domain RNA
binding proteins.
| |
MATERIALS AND METHODS |
|---|
|
|
|---|
Antibodies
Peptides were synthesized at W.M. Keck Biotech Resource Center
(New Haven, CT). Polyclonal antibodies were generated by using New
Zealand White rabbits injected with peptides coupled to keyhole limpet hemocyanin (Sigma-Aldrich, St. Louis, MO). The peptides used to
generate antibodies against asymmetrically dimethylated arginines (UBI,
Upstate USA, Waltham, MA) and PRMT1 were as follows: peptide 24 (KGRGRGRGRGPPPPPRGRGRGRG), where all arginine residues are
asymmetrically dimethylated, and PRMT1 (KTGEEIFGTIGMRPNAKNNRD). The
9E10 anti-myc monoclonal antibody (mAb) was from the American Type
Culture Collection (Manassas, VA). The polyclonal antibodies were
affinity purified over the antigenic peptide coupled to Affigel beads,
eluted with 100 mM glycine pH 2.5, and concentrated by using Centricon
columns (Millipore, Bedford, MA). The anti-Sam68 polyclonal antibody
AD-1 has been described previously (Chen et al., 1999b
). The
anti-SMN mAb was purchased from Transduction Laboratories (Lexington, KY).
Enzyme-linked Immunosorbent Assay (ELISA)
ELISA plates (Costar, Cambridge, MA) were coated with the indicated quantity of peptide in 50 µl of 50 mM carbonate buffer, incubated at 37°C for 30 min, and blocked with blocking buffer (1% bovine serum albumin, 5% sucrose in phosphate-buffered saline [PBS]). Primary antibodies were diluted at 1:1000 in dilution buffer (1% bovine serum albumin, 0.5% ovalbumin, 10 mM Tris pH 7.4, 150 mM NaCl) and added to the corresponding well followed by incubation at 37°C for 30 min. The plate was washed extensively with PBS containing 0.1% Tween. Goat anti-rabbit antibodies covalently coupled to horseradish peroxidase (Cappel Laboratories, Durham, NC) was incubated at 1:1000 in dilution buffer at 37°C for 15 min. The plate was washed and developed using BM Blue POD substrate (Roche Diagnostics, Indianapolis, IN) and quantitated by using spectrophotometry at 405 nm.
DNA Constructs
PRMT1 was amplified from a mouse cDNA library by using
EcoRI oligonucleotides (5'-GGA GAA TTC CTG TGG CCA GGC GGA
AAG-3') and (5'-CCG GAA TTC AGC GCA TCC GGT AGT CGG-3'), subcloned into myc-pcDNA (Chen et al., 1997
) and verified by DNA
sequencing. The T7 promoter expression vectors encoding
Myc-epitope-tagged Sam68, S
N, S
N:
280-339, S
N:
294-339,
S
N:
C, QKI-5, GRP33, SLM-1, SLM-2, and hnRNP K have been described
previously (Chen et al., 1997
; Di Fruscio et al.,
1999
). Mammalian expression vectors for S
N:
280-339,
S
N:
294-339, and S
N:
C were generated by subcloning the
EcoRI fragment in myc-pcDNA. The Sam68- and PRMT1-GST fusion protein were expressed in bacteria by subcloning the full-length EcoRI fragment from myc-Sam68 into pGEX-KG.
Protein Expression
For Figures 1, B and C, 2B, and 3E, proteins were expressed in
HeLa cells by using the vaccinia virus T7 expression system and lysed
in a 1% Triton-based lysis buffer as described previously (Chen
et al., 1997
). In other cases, HeLa cells were transfected with LipofectAMINE PLUS (Invitrogen, Carlsbad, CA) according to manufacturer protocol. For immunoprecipitations, cell lysates were
incubated on ice with the primary antibody for 1 h. Then 20 µl
of a 50% protein A-Sepharose slurry was added and incubated at 4°C
for 30 min with constant end-over-end mixing. The beads were washed
twice with lysis buffer and once with PBS. Protein samples were
analyzed on SDS-polyacrylamide gels and transferred to nitrocellulose
membranes. Immunoblotting was performed using the
anti-myc (9E10) or anti-PRMT1 antibodies. The designated primary antibody was followed by goat anti-mouse or goat anti-rabbit antibodies conjugated to horseradish peroxidase (ICN Pharmaceuticals, Costa Mesa,
CA) and chemiluminescence was used for protein detection (DuPont,
Wilmington, DE).
Mass Spectrometry
Endogenous Sam68 was immunopurified from 5 × 108 HeLa cells by using 1 mg of polyclonal anti-Sam68 antibody (AD1) coupled to 1 g of protein A-Sepharose (Sigma-Aldrich). After extensive washings with lysis buffer, 1× PBS, the bound proteins were eluted with 500 µl of 1× PBS containing 250 µM of the immunogenic Sam68 peptide. Eluted proteins were resolved by SDS-PAGE and revealed by Coomassie Blue R-250 staining. The apparent band at 68 kDa was excised, in-gel digested with trypsin, and sent to the University of Calgary Mass Spectrometry Proteomics Facility for MALDI-TOF analysis on a Voyager DE-STR mass spectrometer.
Methylation Assays
Myc-tagged proteins (PRMT1, Sam68, SLM-1, SLM-2, GRP33, hnRNP K,
or QKI-5) were expressed in HeLa cells and immunoprecipitated with
anti-myc antibodies. The immune complex was incubated with 0.55 µCi
of
[methyl-3H]S-adenosyl-L-methionine
(3H-SAM; PerkinElmer Life Sciences, Boston, MA)
in the presence of 25 mM Tris-HCl at pH 7.5 for 1 h at 37°C in a
final volume of 30 µl. Reactions were stopped by adding 20 µl of
2× SDS-PAGE sample buffer, followed by heating at 100°C for 10 min.
Samples were loaded on 10% SDS-polyacrylamide gels and stained with
Coomassie Blue. The destained gels were soaked in
EN3HANCE (PerkinElmer Life Sciences) according to
manufacturer instructions and visualized by fluorography. In vivo
methylation labeling was performed by metabolically labeling cells with
L-[methyl-3H]methionine
directly in methionine-free medium for 3 h in the presence of
cycloheximide and chloramphenicol as described previously (Liu and
Dreyfuss, 1995
).
L-[35S]methionine was
also used as a control under the same conditions. The cell lysates were
immunoprecipitated and the 3H-labeled proteins
were visualized by fluorography. ES cells were obtained from Earl H. Ruley (Vanderbilt University, Nashville, TN) and were cultured
in the absence of a feeding layer in DMEM (no. 11960-044; Invitrogen)
supplemented with 15% fetal bovine serum, 2%
L-glutamine, 1.2% minimal essential medium
nonessential amino acids (no. 11140-050; Invitrogen), 1.2% Pen/Strep,
1× 2-
-mercaptoethanol, and 0.5 ng/ml leukemia inhibitory factor.
Immunofluorescence Confocal Microscopy
HeLa cells were cultured directly on coverslips in a six-well dish. Cells plated on coverslips were incubate for 24 h with the vehicle (DMSO) or with the methyltransferase inhibitor adenosine-2',3'-dialdehyde (AdOx) (Sigma-Adrich) at a final concentration of 1 mM. Transfection of HeLa cells for immunofluorescence was achieved using LipofectAMINE PLUS (Invitrogen) according to the manufacturer protocol by using 2 µg of DNA. Cells were fixed with 1% paraformaldehyde in 1× PBS at pH 7.4 for 5 min at room temperature (RT) and permeabilized with 0.5% Triton X-100 in PBS for 5 min at RT. The cells were incubated with the primary antibodies at RT for 1 h in PBS. The cells were washed with 0.1% Triton X-100 in PBS and incubated with the appropriate secondary antibodies in PBS. Goat anti-rabbit coupled to Alexa 488 (Molecular Probes, Eugene, OR) and goat anti-mouse coupled to Alexa 546 (Molecular Probes) were used as secondary antibodies. The cells were washed again, mounted onto glass slides, and visualized with a confocal microscope (Carl Zeiss, Thornwood, NY).
Rev Assays
COS cells were transfected with a total of 1 µg of DNA
containing 0.2 µg of Rev response element (RRE) chloramphenicol
acetyltransferase (CAT) reporter plasmid pDM128, 0.7 µg of Rev
expression vector B1-SVH6Rev, 0.7 µg of Rev mutant B1-SVH6RevM10, or
0.7 µg of pcDNA-Sam68, along with increasing concentrations of AdOx
(0, 100, and 250 µM). The
-galactosidase expression vector pCH110
(0.1 µg; Amersham Biosciences, Piscataway, NJ) was included in all
transfections for measuring the efficiency of transfection. Forty-eight
hours after transfection, the cells were collected and resuspended in 150 µl of 0.25 M Tris-HCl, pH 7.8. The cell extracts were prepared by
three freeze-thaw cycles, followed by a brief centrifugation to remove
cell debris. CAT activity was normalized to the
-galactosidase activity and did not exceed twofold.
| |
RESULTS |
|---|
|
|
|---|
Arginine Methylation of Sam68 and Other KH Domain RNA Binding Proteins
Metabolic labeling of HeLa cells by using
L-[methyl-3H]methionine
was performed in the presence of translation inhibitors to examine
whether Sam68 was methylated in vivo. The presence of translation
inhibitors ensured that the labeling was due to posttranslational methylation, not a low level of translational incorporation of L-[methyl-3H]methionine
in newly synthesized proteins (Liu and Dreyfuss, 1995
). Sam68 and a
control known not to be methylated, SMN, were immunoprecipitated from
cells that were metabolically labeled. The immunoprecipitated proteins
were resolved by SDS-PAGE and visualized by fluorography. The
fluorograph revealed that Sam68 was labeled in HeLa cells and that SMN
was not (Figure 1A, lanes 1-4).
Immunoblotting with anti-Sam68 and anti-SMN antibodies
confirm that Sam68 and SMN were immunoprecipitated, respectively
(Figure 1A, lane 5-8). Performing the metabolic labeling with
L-[35S]methionine in the
presence of protein synthesis inhibitors revealed that virtually no
label is incorporated under these conditions (Figure 1A, lane 10). This
control verifies that the protein synthesis inhibitors are functioning
properly. These findings demonstrate that Sam68 is methylated in vivo.
|
Many other KH domain RNA binding proteins contain RG-rich sequences that are potential sites of methylation by PRMTs. The ability of other KH domain RNA binding proteins to become methylated in HeLa cells was examined by a transient transfection assay followed by metabolic labeling with L-[methyl-3H]methionine. Expression vectors encoding myc-epitope-tagged Sam68 (positive control), SLM-1, SLM-2, GRP33, the nuclear QKI-5 isoform, and hnRNP K were transfected in HeLa cells. Anti-myc immunoprecipitates were examined for incorporation of 3H-methyl groups (Figure 1B, lanes 1-6) and protein expression was assessed by immunoblotting total cell lysates (Figure 1B, lanes 7-12). Sam68, SLM-1, SLM-2, GRP33, QKI-5, and hnRNP K were methylated (Figure 1B, lanes 1-6). These findings suggest that many KH domain proteins are methylated in vivo.
PRMTs are known to frequently associate with their substrates (Gary and
Clarke, 1998
). The ability of KH domain proteins to coimmunoprecipitate
PRMT activity was examined in myc immunoprecipitates of cells
transiently transfected with myc-epitope-tagged KH domain RNA binding
proteins. Anti-myc immunoprecipitates were incubated in the presence of
[methyl-3H]S-adenosyl-L-methionine
and the ability of the KH domain RNA binding proteins to serve as an
exogenous substrates was examined. The proteins were resolved by
SDS-PAGE, stained with Coomassie Blue for protein expression (Figure
1C, lanes 7-12), and the methylated proteins were visualized by
fluorography (Figure 1C, lanes 1-6). Sam68, GRP33, hnRNP K, and SLM-2
coimmunoprecipitated protein methyltransferase activity, whereas SLM-1
and QKI-5 did not (Figure 1C, lanes 1-6). The reason for the absence
of protein methyltransferase activity in SLM-1 and QKI-5 is unknown.
Our findings demonstrate that Sam68, GRP33, hnRNP K, and SLM-2 are
methylated in vitro by associated protein methyltransferases.
Association of Sam68 and Other KH Domain RNA Binding Proteins with PRMT1
We have previously reported that the RG repeats flanking the P3
and P4 domains in Sam68 are asymmetrically dimethylated by glutathione
S-transferase (GST)-PRMT1 in vitro (Bedford et
al., 2000
). To determine whether the protein methyltransferase
activity associated with KH-containing RNA binding proteins could be
attributed to endogenous PRMT1, we carried out coimmunoprecipitation
experiments. A polyclonal PRMT1 antibody was generated using a peptide
derived from a unique sequence of PRMT1. The antibody recognized
recombinant GST-PRMT1, but not GST by immunoblotting
(Figure 2A). The antibody recognized a
major protein species of 45 kDa in HeLa cells, corresponding to the
predicted molecular mass of human PRMT1 (Figure 2A, lane 4). The
antibody also recognized proteins with molecular masses of 120, 48, and
42 kDa that were competed away using the immunogenic peptide (Figure
2A, lane 5). The p48 and p42 may represent PRMT1 isoforms, however, the
identity of p120 is unknown.
|
Myc-tagged Sam68, SLM-1, SLM-2, QKI-5, hnRNP K, and GRP33 were expressed in HeLa cells and cell lysates were immunoprecipitated with control mouse IgG or anti-myc antibodies. The presence of coimmunoprecipitating PRMT1 was detected by immunoblotting with anti-PRMT1 antibodies (Figure 2B). Endogenous PRMT1 coimmunoprecipitated with Sam68, SLM-2, hnRNP K, and GRP33 (Figure 2B, lanes 3, 9, 15, and 18). P120, p48, and p42 were visible in total cell lysates (TCL) and anti-myc immunoprecipitations upon longer exposures (our unpublished data). Little or no PRMT1 was detected in SLM-1 and QKI-5 immunoprecipitates (Figure 2B, lanes 6 and 12), consistent with Figure 1C. Equivalent expression of the myc-tagged proteins was assessed by immunoblotting with anti-myc antibodies (Figure 2C). These findings show that the KH domain RNA binding proteins Sam68, SLM-2, hnRNP K, and GRP33 interact with endogenous PRMT1.
Endogenous and Transfected Sam68 Contain Asymmetrical Dimethylated Arginines
The association of Sam68 with PRMT1, a protein methyltransferase
that mediates the generation of aDMAs (Lin et al., 1996
), suggests that Sam68 may contain aDMA in vivo. To examine whether Sam68
contained aDMAs in vivo, we generated an antibody that recognizes aDMA-containing polypeptides (see MATERIALS AND METHODS). Rabbits were
immunized with peptide #24aDMA covalently coupled
to keyhole limpet hemocyanin. The affinity-purified polyclonal
antibody, named ASYM24, recognized strongly the aDMA-containing peptide
#24aDMA, but showed no reactivity to the
unmethylated peptide #24 or to a symmetrical
dimethylarginine-containing peptide #24sDMA
(Figure 3, A and B; peptides
24aDMA, 24 and 24sDMA,
respectively). We examined whether ASYM24 could also recognize any
peptide containing aDMA. ASYM24 was generated using a peptide with
neighboring proline motifs. Three proteins known to have this type of
arrangement are Sam68, hnRNP K, and Wiscott-Aldrich Syndrome protein
(WASP). Peptides from these proteins were generated containing aDMA and
tested by ELISA with ASYM24. ASYM24 only recognized a peptide
containing aDMAs corresponding to the proline motif P3 of Sam68 (Figure
3B). The unmethylated Sam68 P3 peptide was not recognized (Figure 3B).
These results demonstrate that ASYM24 is an aDMA-specific antibody that
has selectivity toward some polypeptides containing aDMA and recognizes
a methylated sequence neighboring the Sam68 proline motif P3.
|
To determine whether full-length Sam68 is recognized by ASYM24,
myc-tagged Sam68 was expressed in HeLa cells. Proteins from cell
lysates were immunoprecipitated with control IgG or anti-myc antibodies. Immunoprecipitated Sam68 was indeed recognized by ASYM24
but not by normal rabbit serum (NRS) or ASYM24 preadsorbed with
the immunogenic peptide (+24 pept.; Figure 3C, lanes 4-12). ASYM24
also recognized unknown endogenous proteins in HeLa cells with
molecular masses of 110 and 75 kDa (lane 7).
Immunoblotting with anti-myc antibodies was carried out
to control for protein expression and efficiency of the
immunoprecipitation procedure (Figure 3C, lanes 1-3). To examine
whether PRMT1 could increase the ASYM24 immunoreactivity of Sam68,
recombinant GST-Sam68 was purified from bacteria, an organism that does
not contain arginine methyltransferase activity (Gary and Clarke,
1998
). The GST-Sam68 fusion protein was left untreated (mock) or
methylated in vitro with purified GST-PRMT1 in the presence of
unlabeled methyl donor S-adenosyl-L-methionine. The level of
methylation was examined by immunoblotting with the
aDMA-specific antibody ASYM24 (Figure 3D). ASYM24 recognized the
methylated GST-Sam68, but not the unmethylated GST-Sam68 (Figure 3D,
lanes 3 and 4). Anti-Sam68 AD1 antibody confirmed equal levels of
GST-Sam68 (Figure 3D, lanes 1 and 2). To verify that this was also true
in vivo, PRMT1 was coexpressed with Sam68 in HeLa cells. Again, the
expression of PRMT1 dramatically increased the ability of Sam68 to be
recognized by ASYM24 (Figure 3E, compare the 68-kDa protein in lanes 3 and 4), further suggesting that PRMT1 is able to methylate Sam68 in
vivo. Finally, we wanted to address whether endogenous Sam68 contained
aDMAs. Lysates were prepared from HeLa and HEK293 cells and
immunoprecipitations were performed with three distinct anti-Sam68
antibodies (polyclonal sc333, AD1, and monoclonal 7-1).
Immunoblotting revealed that endogenous Sam68 from HeLa
and human embryonic kidney (HEK)293 is also recognized by ASYM24
(Figure 3F, lanes 1-9), suggesting that the arginines
neighboring the proline motif P3 of Sam68 are asymmetrically
dimethylated in vivo. The endogenous bands of 110 and 75 kDa recognized
by ASYM24 did not coimmunoprecipitate with Sam68 and are likely to
represent other asymmetrically dimethylated proteins in the cell
(Figure 3F).
To determine whether other regions of Sam68 were methylated,
matrix-assisted laser desorption ionization/time of flight (MALDI-TOF) mass spectrometry was carried out with endogenous Sam68 purified from
HeLa cells. Three domains of Sam68 harbor arginine-glycine motifs that
could potentially be methylated (Table 1;
P0, P3, and P4). By knowing that methylation of arginines prevents
cleavage by trypsin (Baldwin and Carnegie, 1971
), predicted peptide
sizes that would result from monomethylated or dimethylated arginines were calculated and compared with the peptide masses identified by
MALDI-TOF mass spectrometry. Arginines at position 45 and 52 were found
to be dimethylated (Table 1). However, some peptides contained
dimethylated R45 but unmodified R52, perhaps indicating that R45 is
methylated first, followed by R52. No peptides containing only
monomethylated arginines were identified for this region. These two
arginines are the only arginines followed by two glycines, which is
characteristic of the RGG motif found in hnRNPs. Arginines 310, 315, 320, and 325, which are located in between the proline motifs P3 and P4
were found to be monomethylated (Table 1). No peptides containing
dimethylated arginines were identified for this region, indicating that
those arginines are mostly found monomethylated endogenously.
Interestingly, these arginines are each distanced by exactly four amino
acids and are part of a distinct RG(A/T)XV motif. Finally, arginine
304, the second arginine in the RGRG motif downstream of the proline
motif P3, was found to be dimethylated (but never monomethylated),
whereas arginine 302 was unmodified. The absence of peptides containing
methylated arginines from the region upstream of proline motif P3 is
likely due to technical limitations (i.e., inability to detect very
small or very large peptides). Overall, this analysis has revealed that Sam68 is endogenously methylated at least on seven of the 14 arginines found in an arginine-glycine context.
|
RG Sequences Neighboring Sam68 Proline Motif P3 Are Methylated
To address whether the RG repeats upstream of the proline motif P3
are methylated in vivo, we performed the methylation labeling assay by
using Sam68 deletion mutants (Figure 4A).
A Sam68 protein was engineered that removed all the RG repeats
surrounding P3 except one (S
N:
280-339). An expression vector
encoding S
N:
280-339 was transfected in HeLa cells, the cells
were metabolically labeled and the level of in vivo methylation
assessed by immunoprecipitating with anti-myc antibodies followed by
SDS-PAGE and fluorography. S
N:
280-339 was unable to incorporate
3H-methyl groups (Figure 4B, lane 2). Note that
all arginines found to be methylated in the analysis by mass
spectrometry are missing in the deletion mutant S
N:
280-339,
which is not methylated at all upon transfection. Two additional
constructs were generated: one that added four RG repeats N-terminal to
the proline motif P3 (S
N:
294-339) and the other that restored
the entire RG-rich region between proline motifs P3 and P4
(S
N:
C). Both S
N:
294-339 and S
N:
C proteins were
methylated in vivo, indicating that at least one of the RGs upstream of
P3 is methylated (Figure 4B, lanes 3 and 4). Equivalent expression of
myc-tagged proteins was confirmed by anti-myc
immunoblotting of HeLa total cell lysates (Figure 4B,
lanes 5-8). The deletion analysis has demonstrated that the RGs
upstream of P3 (aa 280-294) are sufficient to observe in vivo
methylation.
|
Methylation of Sam68 Is Required for Its Nuclear Localization
To determine whether methylation regulates Sam68 localization,
HeLa cells were transfected with the Sam68 expression vectors encoding
the various Sam68 deletion proteins described above. The cells were
fixed, permeabilized, and the localization of myc-epitope-tagged Sam68
was detected by indirect immunofluorescence. The unmethylated Sam68
protein (S
N:
280-339) had a whole cell distribution and behaved
somewhat like a Sam68 devoid of its C-terminal nuclear localization
signal (S
N:
C; Figure 4C). Interestingly, the addition of four RG
repeats that results in the methylation of Sam68 (S
N:
294-339) was sufficient to concentrate Sam68 in the nucleus, as observed with
the wild-type protein (Figure 4C). These results uncover a direct
correlation between the methylation of Sam68 (amino acids 280-294) and
the cellular localization of the protein. Moreover, the fact that the
cytoplasmic Sam68 protein (S
N:
C) was methylated suggests that
methylation of Sam68 can occur in the cytoplasm.
PRMT1 is thought to reside predominantly in the nucleus (Tang et
al., 1998
); however, it has been identified through purification from a cytoplasmic macromolecular complex (Lin et al.,
1996
). To further examine the localization of PRMT1, we transfected
HeLa cells and performed indirect immunofluorescence by using anti-myc antibodies (Figure 4D). PRMT1 was localized mostly in the cytoplasm, although some of the cells showed both cytoplasmic and nuclear staining. The anti-PRMT1 antibodies were also used for
immunofluorescence studies and were unable to stain endogenous PRMT1
(our unpublished data), perhaps indicating that our peptide
antibody does not recognize the native folded protein or that PRMT1 is
present in large complexes inaccessible to our antibody. A GFP-PRMT1
was recently reported to reside in both cellular compartments (Frankel
et al., 2002
).
To confirm that methylation of endogenous Sam68 is required for its
nuclear localization, we examined whether methylase inhibitors could
affect Sam68 cellular distribution. HeLa cells were treated with the
drug vehicle dimethyl sulfoxide (DMSO, Figure
5, A and C) or with 1 mM AdOx (Figure 5,
B and D) for 24 h. The cells were fixed, permeabilized, and
immunofluorescence was performed using the anti-Sam68 AD1 antibody
(Figure 5, C and D). The treatment of Sam68 with DMSO did not alter the
localization of Sam68 in the nucleoplasm and in Sam68/SLM nuclear
bodies (SNBs; Chen et al., 1999b
). The methylase inhibitor
AdOx increased the cytoplasmic staining of Sam68 and SNBs were not
visible (Figure 5D). Strikingly, the distribution of Sam68 in both the
cytoplasm and the nucleus was comparable with the nonmethylated mutant
S
N:
280-339. To show that Sam68 methylation was effectively
reduced by the AdOx treatment, we performed metabolic labeling to
assess the levels of protein methylation (Figure 5E). A drastic
reduction of Sam68 methylation was observed in the presence of AdOx and
no change in protein level was observed (Figure 5E). Comparable results were obtained using another general methylation inhibitor
5'-deoxy-5'-methylthioadenosine (our unpublished data). These
results suggest that arginine methylation is essential for the normal
localization of Sam68.
|
Abrogation of Sam68 Arginine Methylation in PRMT1
/
Embryonic
Cells
To provide definitive proof for the involvement of PRMT1 in the
methylation of Sam68 in vivo, we made use of embryonic stem (ES) cells
in which insertion of a gene trap retrovirus into the second intron of
the prmt1 gene has created essentially a null mutation
(Pawlak et al., 2000
). Ruley and coworkers reported that low
levels of prmt1 transcripts (~1% of wild-type levels) can be detected in
/
ES cells (Pawlak et al., 2000
).
Consistent with this observation, our PRMT1 antibody permitted the
detection of very low residual levels of PRMT1 in
/
ES cells
(Figure 6A, compare lanes 1 and 3). Among
the additional polypeptides that our antibody recognizes, p42 and p48
are also reduced, but p120 levels remain identical (Figure 6A, lanes
1-3), suggesting it represents a cross-reacting band that is not
related to PRMT1. Numerous proteins can be detected in wild-type ES
cells by immunoblotting with our ASYM24 aDMA-specific
antibody (Figure 6A, lane 4). As expected if PRMT1 activity is greatly
reduced, the majority of these polypeptides are no longer recognized by
ASYM24 in PRMT1
/
ES cells (Figure 6A, lane 6).
|
Metabolic labeling using
L-[methyl-3H]methionine
was performed in the presence of translation inhibitors to examine the
methylation state of Sam68 in these cells where PRMT1 activity was
greatly reduced. Immunoprecipitations were carried out with normal
rabbit serum (CTRL), anti-Sam68, or anti-SMN antibodies. The
immunoprecipitated proteins were resolved by SDS-PAGE and visualized by
fluorography. The fluorograph revealed that Sam68 methylation was
severely abrogated in PRMT1
/
ES cells (Figure 6B, compare lanes 2 and 10). As expected and shown in Figure 1A, SMN did not incorporate
any [3H]methionine (Figure 6B, lanes 4, 8, and
12). Immunoblotting with anti-Sam68 and anti-SMN
antibodies confirmed that Sam68 and SMN were present in equal amounts
in each cell extracts (Figure 6B, lanes 13-15 and 16-18,
respectively). These findings clearly establish PRMT1 as an enzyme
responsible for the methylation of Sam68 in vivo.
We next examined the cellular localization of Sam68 in PRMT1-deficient
ES cells because Sam68 is no longer methylated in these cells (Figure
6). Indirect immunofluorescence was performed as described above by
using the anti-Sam68 AD1 antibody and the cells were visualized using a
confocal microscope (Carl Zeiss). ES cells carrying both wild-type
alleles of PRMT1 (+/+) showed a normal nuclear localization of Sam68
(Figure 7, A and B). In contrast, some
cytoplasmic staining of Sam68 was detectable in PRMT1
/
cells
(Figure 7, C and D). These results confirm that Sam68 arginine methylation by PRMT1 influences its cellular localization.
|
Methylation Is Necessary for Ability of Sam68 to Function in Nuclear Export of HIV RNAs
Sam68 has been shown to function as a cellular homologue of Rev in
accelerating the transport of HIV RNAs from the nucleus to the
cytoplasm (Reddy et al., 1999
). We examined whether arginine methylation could regulate this function of Sam68 by determining whether methylase inhibitors could modulate RRE-directed reporter gene
expression (Figure 8). Transport to the
cytoplasm and expression of the intronic CAT gene is Rev and RRE
dependent, as described previously (Hope et al., 1990
). COS7
cells were transfected with the RRE-CAT reporter plasmid in the
presence of either an empty plasmid (pcDNA), expression vectors for
Rev, an inactive mutant of Rev (Rev M10), and Sam68. After
transfection, cells were treated with increasing concentrations of AdOx
or DMSO and harvested for CAT activity (Figure 8). The transfection of
Sam68 or Rev with the RRE-CAT reporter resulted in an approximately
fivefold increase in CAT activity relative to an empty plasmid or
RevM10 (Figure 8). The presence of the methylase inhibitor AdOx
decreased CAT activity in a dose-dependent manner in Sam68, but not
Rev-transfected cells (Figure 8). Sam68 deletion mutants
(S
N:
280-339 and S
N:
294-339) were unable to substitute for
Rev in this assay, although they did not act as dominant negative as
was reported for the S
N:
C mutant (our unpublished data;
Reddy et al., 1999
). These findings suggest that arginine
methylation of Sam68 regulates its ability to export RRE-containing HIV
RNAs.
|
| |
DISCUSSION |
|---|
|
|
|---|
Herein, we report that the KH domain containing Sam68 harbors asymmetric dimethylarginines near its proline motif P3 in vivo by using a novel anti-aDMA-specific antibody. PRMT1 interacts with Sam68 and is a major PRMT responsible for Sam68 methylation in vivo. Arginine methylation was necessary to localize Sam68 to the nucleoplasm, where it normally resides. The methylation of Sam68 was required for its ability to facilitate the export of unspliced HIV RNAs into the cytoplasm. We demonstrate that other KH domain RNA binding proteins, including SLM-1, SLM-2, QKI-5, hnRNP K, and GRP33 are also methylated in vivo. Our findings suggest that arginine methylation may be an essential maturation step for the proper localization and function of RG-rich-containing RNA binding proteins.
Sam68 and Other KH Domain-containing Proteins Interact with PRMT1
The association of KH domain RNA binding proteins with PRMT1
demonstrates a link between RNA and PRMT1. The disruption of ribonucleoprotein complexes by RNase treatment increases the
accessibility of proteins to in vitro methylation by PRMT1 (Frankel and
Clarke, 1999
). Moreover, the yeast Hmt1p/Rmt1p was identified in a
screen for interactors of poly-(A)-associated proteins (Henry and
Silver, 1996
). These observations suggest that PRMTs are present in
ribonucleoprotein complexes with their substrates.
SLM-1 and QKI-5 are methylated in vivo, but did not coimmunoprecipitate a protein methyltransferase activity and did not interact with PRMT1. Thus, SLM-1 and QKI-5 may be the target for a different PRMT that may not require a tight interaction with its substrates for activity. The fact that SLM-1 did not associate with PRMT1 is surprising because it shares a high degree of homology with Sam68 and SLM-2 and thus has a comparable number of RG repeats. Examining the RG sequences in SLM-1, compared with those of Sam68 and SLM-2 might provide new insights about the preferred motif of PRMT1 vs. other PRMTs. We have found that QKI-5 is weakly methylated in vivo. But what seems to be weak in vivo methylation could in fact be the lower amount of incorporated labeled methyl groups due to the few RG repeats found in QKI-5.
By using biochemical methods, it has been previously shown in insect
cells that Sam68 contained methylated arginines in its sequence (Wong
et al., 1992
). We now provide evidence by using a novel
aDMA-specific antibody that mammalian Sam68 harbors aDMA in vivo. The
sites of arginine methylation are two hnRNP-like RGG motifs at position
45 and 52 in the N-terminal region as well as multiple RG repeats
surrounding proline motif P3 as determined by mass spectrometry.
Furthermore, the deletion analysis revealed that at least one arginine
is methylated between amino acids 280-294 upstream of proline motif
P3. All these methylation sites fit the PRMT1 GAR and RxR consensus
sequence (Gary and Clarke, 1998
; Smith et al., 1999
).
Interestingly, four RG repeats (310, 315, 320, and 325) located between
proline motifs P3 and P4 were found to be monomethylated. It remains to
be determined whether these represent precursors or intermediates
leading to dimethylation. Arginine 3 of histone H4 has been shown to
contain monomethylated arginines at steady state, and PRMT1 is thought
to be the major, if not exclusive, methyltransferase responsible for
this modification (Strahl et al., 2001
).
Arginine Methylation Affects Sam68 Cellular Distribution
The present study shows that arginine methylation of Sam68
is a prerequisite for its exclusive nuclear localization. HnRNP A2,
another RNA binding protein methylated by PRMT1, accumulates in the
cytoplasm in the presence of general methylation inhibitors and its
nuclear localization requires an intact RGG domain (Nichols et
al., 2000
). Similarly, nuclear accumulation of
high-molecular-weight fibroblast growth factor-2 could also be linked
to methylation (Pintucci et al., 1996
). These observations
suggest that arginine methylation of RNA binding proteins regulates
their nucleocytoplasmic transport. Indeed, arginine methylation
facilitates the nuclear export of Npl3p, Nab2p, and Hrp1p in yeast and
the methyltransferase activity of Hmt1p is required for this effect
(Shen et al., 1998
; McBride et al., 2000
; Green
et al., 2002
). Moreover, arginine methylation of Npl3p RGG
motif interferes with its Sky1p-mediated phosphorylation, which in turn
prevents the interaction of Npl3p with the nuclear import receptor
Mtr10p (Yun and Fu, 2000
). This provides an indirect mechanism by which
arginine methylation can affect nuclear import. The reason for Sam68
cytoplasmic accumulation is unknown, but it can be reasoned that 1)
arginine methylation is cotranslational and newly synthesized Sam68
accumulates in the cytoplasm, or 2) unmethylated Sam68 is imported at a
slower rate than it is exported. The use of protein synthesis
inhibitors with methylase inhibitors rule out the first possibility.
Thus, the likely possibility is that the nucleocytoplasmic transport of
Sam68 is altered by methylation. This is consistent with the fact that
Sam68 cannot functionally export HIV RNAs in the presence of methylase inhibitors.
Arginine Methylation: A Maturation Step for RNA Binding Proteins?
The presence of conserved RGG boxes and RG-rich repeats in RNA
binding proteins is thought to be necessary to mediate interactions with RNA. Indeed, this has been demonstrated for several RNA binding proteins, including Sam68, FMRP, hnRNP A1, and U (Kiledjian and Dreyfuss, 1992
; Chen et al., 2001
; Darnell et
al., 2001
). A major family of proteins containing aDMAs is the
hnRNP RNA binding proteins (Liu and Dreyfuss, 1995
) and the presence
of aDMAs in other RNA binding proteins is rapidly being discovered.
What may be the role of arginine methylation in the function and/or
turnover of RNA binding proteins? It is conceivable that arginine
methylation could modulate the contribution of RNA binding by the
arginine-rich regions. Methylation does not change the positive charge
of the arginines, but increases hydrophobicity and might prevent
hydrogen bonding and/or introduce steric constraints that should reduce charge-induced interactions with RNA (Calnan et al., 1991
).
In agreement with this prediction, a reduction in hnRNP A1 binding to
nonspecific single-stranded nucleic acid was observed subsequent to its
arginine methylation (Rajpurohit et al., 1994
). However, other studies have reported no significant effect of arginine methylation on RNA binding (Valentini et al., 1999
; Raman
et al., 2001
). We have observed a modest effect of arginine
methylation on Sam68 RNA binding activity in vitro, by using gel
mobility shift assays and poly (U) homopolymer binding assays (our
unpublished data). However, no difference in Sam68 binding to
poly (U)-Sepharose could be detected between PRMT1 +/+ and PRMT1
/
ES cell extracts (our unpublished data). Nonetheless, arginine
methylation might affect interactions with specific RNA targets or
structures that would have evolved to better accommodate the bulkier
methyl groups. It is becoming increasingly clear that arginine
methylation will not be a quick and rapid mode of regulation such as
phosphorylation. Our data with Sam68 support the hypothesis that
arginine methylation may be a maturation step for certain proteins such
as RNA binding proteins. We define maturation as a step necessary for
the proper localization of a protein and a step that is required to
enhance its function. This maturation step may be either
cotranslational or coupled to the nuclear import machinery. Because
arginine methylation is most likely irreversible (Gary and Clarke,
1998
), it may be a constitutive pathway for the maturation of proteins.
Interestingly, four of the 12 neighboring Sam68 RG repeats were
sufficient to properly localize Sam68 in the nucleus, implying that
partial methylation may be sufficient to target the protein to its
proper localization. The methylation of the RG repeats of Sam68 may be regulated and occur initially in the cytoplasm and then in the nucleus.
Moreover, the level of RG methylation of certain proteins may reflect
the "age" of the protein. The presence of multiple neighboring RG
repeats also implies that methylation may be a processive event,
especially because PRMTs associate with their substrates. The
maturation hypothesis our data supports may apply to histones and Sm proteins.
In summary, this study demonstrates that Sam68 is asymmetrically dimethylated on several arginine residues by PRMT1 in vivo. This modification is required for proper Sam68 localization in the nucleus and for one of its functions, the ability to substitute for Rev in exporting unspliced HIV RNAs. These results suggest a general role for arginine methylation in the maturation and function of RNA binding proteins.
| |
ACKNOWLEDGMENTS |
|---|
We thank Dave Schriemer (University of Calgary, Alberta,
Calgary, Canada) for the mass spectrometry analysis and Yi Zhang and
Earl H. Ruley for kindly providing PRMT1
/
ES cells. This work was
supported by grant 011291 from the National Cancer Institute of Canada
with funds from the Canadian Cancer Society of Canada and grant MT13377
from the Canadian Institutes of Health Research. F.-M.B. and J.C. are
recipients of a studentship and a postdoctoral fellowship from the
National Cancer Institute of Canada, respectively. M.T.B. is supported
by a Welch Foundation grant (G-1495). S.R. is a recipient of a Canadian
Institutes of Health Research Investigator award.
| |
FOOTNOTES |
|---|
These authors contributed equally to this work.
§ Corresponding author. E-mail address: stephane.richard{at}mcgill.ca.
Article published online ahead of print. Mol. Biol. Cell 10.1091/mbc.E02-08-0484. Article and publication date are at www.molbiolcell.org/cgi/doi/10.1091/mbc.E02-08-0484.
| |
REFERENCES |
|---|
|
|
|---|
This article has been cited by other articles:
![]() |
Z. Yu, T. Chen, J. Hebert, E. Li, and S. Richard A Mouse PRMT1 Null Allele Defines an Essential Role for Arginine Methylation in Genome Maintenance and Cell Proliferation Mol. Cell. Biol., June 1, 2009; 29(11): 2982 - 2996. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Xie, S. Ke, N. Ouyang, J. He, W. Xie, M. T. Bedford, and Y. Tian Epigenetic Regulation of Transcriptional Activity of Pregnane X Receptor by Protein Arginine Methyltransferase 1 J. Biol. Chem., April 3, 2009; 284(14): 9199 - 9205. [Abstract] [Full Text] [PDF] |
||||
![]() |
M.-E. Huot, C. M. Brown, N. Lamarche-Vane, and S. Richard An Adaptor Role for Cytoplasmic Sam68 in Modulating Src Activity during Cell Polarization Mol. Cell. Biol., April 1, 2009; 29(7): 1933 - 1943. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. PAPADOKOSTOPOULOU, K. MATHIOUDAKI, A. SCORILAS, D. XYNOPOULOS, A. ARDAVANIS, E. KOUROUMALIS, and M. TALIERI Colon Cancer and Protein Arginine Methyltransferase 1 Gene Expression Anticancer Res, April 1, 2009; 29(4): 1361 - 1366. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Herrmann, P. Pably, C. Eckerich, M. T. Bedford, and F. O. Fackelmayer Human protein arginine methyltransferases in vivo - distinct properties of eight canonical members of the PRMT family J. Cell Sci., March 1, 2009; 122(5): 667 - 677. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Matsuda, B. D. Paul, C. Y. Choi, T. Hasebe, and Y.-B. Shi Novel Functions of Protein Arginine Methyltransferase 1 in Thyroid Hormone Receptor-Mediated Transcription and in the Regulation of Metamorphic Rate in Xenopus laevis Mol. Cell. Biol., February 1, 2009; 29(3): 745 - 757. [Abstract] [Full Text] [PDF] |
||||
![]() |
N.-z. Lei, X.-y. Zhang, H.-z. Chen, Y. Wang, Y.-y. Zhan, Z.-h. Zheng, Y.-m. Shen, and Q. Wu A feedback regulatory loop between methyltransferase PRMT1 and orphan receptor TR3 Nucleic Acids Res., February 1, 2009; 37(3): 832 - 848. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Chawla, C.-H. Lin, A. Han, L. Shiue, M. Ares Jr., and D. L. Black Sam68 Regulates a Set of Alternatively Spliced Exons during Neurogenesis Mol. Cell. Biol., January 1, 2009; 29(1): 201 - 213. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. Goulet, S. Boisvenue, S. Mokas, R. Mazroui, and J. Cote TDRD3, a novel Tudor domain-containing protein, localizes to cytoplasmic stress granules Hum. Mol. Genet., October 1, 2008; 17(19): 3055 - 3074. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Fronz, S. Otto, K. Kolbel, U. Kuhn, H. Friedrich, A. Schierhorn, A. G. Beck-Sickinger, A. Ostareck-Lederer, and E. Wahle Promiscuous Modification of the Nuclear Poly(A)-binding Protein by Multiple Protein-arginine Methyltransferases Does Not Affect the Aggregation Behavior J. Biol. Chem., July 18, 2008; 283(29): 20408 - 20420. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. M. Lakowski and A. Frankel A Kinetic Study of Human Protein Arginine N-Methyltransferase 6 Reveals a Distributive Mechanism J. Biol. Chem., April 11, 2008; 283(15): 10015 - 10025. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Tadesse, J. Deschenes-Furry, S. Boisvenue, and J. Cote KH-type splicing regulatory protein interacts with survival motor neuron protein and is misregulated in spinal muscular atrophy Hum. Mol. Genet., February 14, 2008; 17(4): 506 - 524. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. Goulet, G. Gauvin, S. Boisvenue, and J. Cote Alternative Splicing Yields Protein Arginine Methyltransferase 1 Isoforms with Distinct Activity, Substrate Specificity, and Subcellular Localization J. Biol. Chem., November 9, 2007; 282(45): 33009 - 33021. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. E. McBride, C. Zurita-Lopez, A. Regis, E. Blum, A. Conboy, S. Elf, and S. Clarke Protein Arginine Methylation in Candida albicans: Role in Nuclear Transport Eukaryot. Cell, July 1, 2007; 6(7): 1119 - 1129. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Bachand Protein Arginine Methyltransferases: from Unicellular Eukaryotes to Humans Eukaryot. Cell, June 1, 2007; 6(6): 889 - 898. [Full Text] [PDF] |
||||
![]() |
B. Xie, C. F. Invernizzi, S. Richard, and M. A. Wainberg Arginine Methylation of the Human Immunodeficiency Virus Type 1 Tat Protein by PRMT6 Negatively Affects Tat Interactions with both Cyclin T1 and the Tat Transactivation Region J. Virol., April 15, 2007; 81(8): 4226 - 4234. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. P. Paronetto, T. Achsel, A. Massiello, C. E. Chalfant, and C. Sette The RNA-binding protein Sam68 modulates the alternative splicing of Bcl-x J. Cell Biol., March 26, 2007; 176(7): 929 - 939. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Perreault, C. Lemieux, and F. Bachand Regulation of the Nuclear Poly(A)-binding Protein by Arginine Methylation in Fission Yeast J. Biol. Chem., March 9, 2007; 282(10): 7552 - 7562. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. C. Goulah and L. K. Read Differential Effects of Arginine Methylation on RBP16 mRNA Binding, Guide RNA (gRNA) Binding, and gRNA-containing Ribonucleoprotein Complex (gRNP) Formation J. Biol. Chem., March 9, 2007; 282(10): 7181 - 7190. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Robin-Lespinasse, S. Sentis, C. Kolytcheff, M.-C. Rostan, L. Corbo, and M. Le Romancer hCAF1, a new regulator of PRMT1-dependent arginine methylation J. Cell Sci., February 15, 2007; 120(4): 638 - 647. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. El-Andaloussi, T. Valovka, M. Toueille, P. O. Hassa, P. Gehrig, M. Covic, U. Hubscher, and M. O. Hottiger Methylation of DNA polymerase {beta} by protein arginine methyltransferase 1 regulates its binding to proliferating cell nuclear antigen FASEB J, January 1, 2007; 21(1): 26 - 34. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. P. Tan and S. Nakielny Control of the DNA Methylation System Component MBD2 by Protein Arginine Methylation. Mol. Cell. Biol., October 1, 2006; 26(19): 7224 - 7235. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. O. Yildirim, P. Bulau, D. Zakrzewicz, K. E. Kitowska, N. Weissmann, F. Grimminger, R. E. Morty, and O. Eickelberg Increased Protein Arginine Methylation in Chronic Hypoxia: Role of Protein Arginine Methyltransferases Am. J. Respir. Cell Mol. Biol., October 1, 2006; 35(4): 436 - 443. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. C. Goulah, M. Pelletier, and L. K. Read Arginine methylation regulates mitochondrial gene expression in Trypanosoma brucei through multiple effector proteins RNA, August 1, 2006; 12(8): 1545 - 1555. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Shire, P. Kapoor, K. Jiang, M. N. T. Hing, N. Sivachandran, T. Nguyen, and L. Frappier Regulation of the EBNA1 Epstein-Barr Virus Protein by Serine Phosphorylation and Arginine Methylation. J. Virol., June 1, 2006; 80(11): 5261 - 5272. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Dolzhanskaya, G. Merz, J. M. Aletta, and R. B. Denman Methylation regulates the intracellular protein-protein and protein-RNA interactions of FMRP. J. Cell Sci., May 1, 2006; 119(Pt 9): 1933 - 1946. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Ostareck-Lederer, D. H. Ostareck, K. P. Rucknagel, A. Schierhorn, B. Moritz, S. Huttelmaier, N. Flach, L. Handoko, and E. Wahle Asymmetric Arginine Dimethylation of Heterogeneous Nuclear Ribonucleoprotein K by Protein-arginine Methyltransferase 1 Inhibits Its Interaction with c-Src J. Biol. Chem., April 21, 2006; 281(16): 11115 - 11125. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Fujiwara, Y. Mori, D. L. Chu, Y. Koyama, S. Miyata, H. Tanaka, K. Yachi, T. Kubo, H. Yoshikawa, and M. Tohyama CARM1 Regulates Proliferation of PC12 Cells by Methylating HuD. Mol. Cell. Biol., March 1, 2006; 26(6): 2273 - 2285. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. E. Lukong, D. Larocque, A. L. Tyner, and S. Richard Tyrosine Phosphorylation of Sam68 by Breast Tumor Kinase Regulates Intranuclear Localization and Cell Cycle Progression J. Biol. Chem., November 18, 2005; 280(46): 38639 - 38647. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Herrmann, J. Lee, M. T. Bedford, and F. O. Fackelmayer Dynamics of Human Protein Arginine Methyltransferase 1(PRMT1) in Vivo J. Biol. Chem., November 11, 2005; 280(45): 38005 - 38010. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Cote and S. Richard Tudor Domains Bind Symmetrical Dimethylated Arginines J. Biol. Chem., August 5, 2005; 280(31): 28476 - 28483. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Blanchet, A. Cardona, F. A. Letimier, M. S. Hershfield, and O. Acuto CD28 costimulatory signal induces protein arginine methylation in T cells J. Exp. Med., August 1, 2005; 202(3): 371 - 377. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Y. Lee, C. Teyssier, B. D. Strahl, and M. R. Stallcup Role of Protein Methylation in Regulation of Transcription Endocr. Rev., April 1, 2005; 26(2): 147 - 170. [Abstract] [Full Text] [PDF] |
||||
![]() |
F.-M. Boisvert, U. Dery, J.-Y. Masson, and S. Richard Arginine methylation of MRE11 by PRMT1 is required for DNA damage checkpoint control Genes & Dev., March 15, 2005; 19(6): 671 - 676. [Abstract] [Full Text] [PDF] |
||||
![]() |
F.-M. Boisvert, C. A. Chenard, and S. Richard Protein Interfaces in Signaling Regulated by Arginine Methylation Sci. Signal., February 15, 2005; 2005(271): re2 - re2. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Haegebarth, D. Heap, W. Bie, J. J. Derry, S. Richard, and A. L. Tyner The Nuclear Tyrosine Kinase BRK/Sik Phosphorylates and Inhibits the RNA-binding Activities of the Sam68-like Mammalian Proteins SLM-1 and SLM-2 J. Biol. Chem., December 24, 2004; 279(52): 54398 - 54404. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Herrmann, M. Bossert, A. Schwander, E. Akgun, and F. O. Fackelmayer Arginine Methylation of Scaffold Attachment Factor A by Heterogeneous Nuclear Ribonucleoprotein Particle-associated PRMT1 J. Biol. Chem., November 19, 2004; 279(47): 48774 - 48779. [Abstract] [Full Text] [PDF] |
||||
![]() |
D.-H. Chen, K.-T. Wu, C.-J. Hung, M. Hsieh, and C. Li Effects of Adenosine Dialdehyde Treatment on In Vitro and In Vivo Stable Protein Methylation in HeLa Cells J. Biochem., September 1, 2004; 136(3): 371 - 376. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. P. Venables, C. Dalgliesh, M. P. Paronetto, L. Skitt, J. K. Thornton, P. T. Saunders, C. Sette, K. T. Jones, and D. J. Elliott SIAH1 targets the alternative splicing factor T-STAR for degradation by the proteasome Hum. Mol. Genet., July 15, 2004; 13(14): 1525 - 1534. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Kim, J. Lee, N. Yadav, Q. Wu, C. Carter, S. Richard, E. Richie, and M. T. Bedford Loss of CARM1 Results in Hypomethylation of Thymocyte Cyclic AMP-regulated Phosphoprotein and Deregulated Early T Cell Development J. Biol. Chem., June 11, 2004; 279(24): 25339 - 25344. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Cheng, N. Yadav, R. W. King, M. S. Swanson, E. J. Weinstein, and M. T. Bedford Small Molecule Regulators of Protein Arginine Methyltransferases J. Biol. Chem., June 4, 2004; 279(23): 23892 - 23899. [Abstract] [Full Text] [PDF] |
||||
![]() |
X. Liang, Y. Lu, M. Wilkes, T. A. Neubert, and M. D. Resh The N-terminal SH4 Region of the Src Family Kinase Fyn Is Modified by Methylation and Heterogeneous Fatty Acylation: ROLE IN MEMBRANE TARGETING, CELL ADHESION, AND SPREADING J. Biol. Chem., February 27, 2004; 279(9): 8133 - 8139. [Abstract] [Full Text] [PDF] |
||||
![]() |
F.-M. Boisvert, J. Cote, M.-C. Boulanger, and S. Richard A Proteomic Analysis of Arginine-methylated Protein Complexes Mol. Cell. Proteomics, December 1, 2003; 2(12): 1319 - 1330. [Abstract] [Full Text] [PDF] |
||||
![]() |
U. Kuhn, A. Nemeth, S. Meyer, and E. Wahle The RNA Binding Domains of the Nuclear poly(A)-binding Protein J. Biol. Chem., May 2, 2003; 278(19): 16916 - 16925. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||